Rasburicase in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer or Other Disease Undergoing Donor Stem Cell Transplant

计划入组 46 人 · 首次发布于 2007 年 8 月 8 日

Rapamycin for Prevention of Chronic Graft-Versus-Host Disease

计划入组 2 人 · 首次发布于 2008 年 2 月 25 日

The Skin Microbiome in Graft Versus Host Disease

计划入组 74 人 · 首次发布于 2020 年 1 月 18 日

Graft-versus-host disease therapeutics (Mallinckrodt)

Graft-versus-host disease therapy(Applied StemCell, Inc.)

CCL1 modulators (protein, inflammation/autoimmune diseases/graft versus host disease)

Theriva Biologics

United States

Vascular Graft Solutions Ltd.

Israel

Rare Disease Research, LLC

Graves' Disease and Graft-versus-Host Disease: Pipeline Therapeutics Update

FDA Approves Belumosudil for Chronic Graft-Versus-Host Disease Treatment

Ibrutinib Shows Promise in Treating Chronic Graft-Versus-Host Disease